Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

British Global Health Advocate Says He Was Denied Entrance Into U.S. Because Of HIV Status
Paul Thorn - project director of the Tuberculosis Survival Project, who was scheduled to speak at the Pacific Health Summit in Seattle on Wednesday - has called on the Obama administration to change the policy banning people who are HIV-positive from entering the U.S., the Seattle Times" blog, the "Business of Giving," reports. Thorn said he was denied a U.S. visa because he is HIV-positive and issued an apology to summit attendees for his absence, which stated, "The U.S. government actively discriminates against people" who are HIV-positive adding that if U.S. officials want to demonstrate leadership on HIV/AIDS and global health by hosting such conferences, "then they need to accept that non-U.S. citizens with HIV are going to need to be there and participate." One of the key topics for the conference is HIV and tuberculosis coinfection (Heim, "Business of Giving"/Seattle Times, 6/17).
generic viagra online
International Action Needed To Combat Epidemic Of Noncommunicable Diseases
IDF, WHF and UICC join forces
News of the day
Availability Of IVF Treatment In UK Still Poor Compared With Rest Of Europe
Commenting on the news announced today by ESHRE"s European IVF monitoring consortium on the improvements in the quality, safety and efficacy of ART, Clare Lewis-Jones MBE, Chief Executive of Infertility Network UK said "We are angry that although the UK pioneered infertility treatment, we are still among the lowest providers in Europe of NHS treatment, and these figures show that availability in the UK is less than one third of that in Denmark. Recent measures announced by the Government to encourage implementation of the NICE Guideline have led to an improvement in the provision in some areas but more needs to be done by Primary Care Trusts in England to ensure that patients have equal and timely access to the full range of treatment recommended by NICE, and to tackle the ongoing variations in provision that exist across the country.
Public Health

GTCbio Announces Its 4th Annual Assay Development And Screening Technologies Conference Taking Place On June 8-9, 2009 In San Francisco

GTCbio Announces 4th Annual Assay Development and Screening Conference taking place June 8-9, 2009. As compounds derived from high throughput screening increasingly find their way into clinical trials, drug screening has become widely accepted as a critical step in the drug discovery process. After more than a decade of rapid growth, tremendous progress has been made in assay technology, laboratory automation, and informatics. These technological developments have not only facilitated a drastic increase in throughput and efficiency in drug screening, but have also provided novel solutions in other areas of drug discovery and development. As screening has also become prominent in biological research, screening facilities have become increasingly popular in academic institutions. As the pharmaceutical industry continues to face the challenges of developing more new chemical entities and reducing the cost of R&D, the demand for novel technologies and creative approaches for improving the efficiency of screening has intensified. Cell-based assays used in compound screening and high-content screening technologies have gained popularity in the industry. Years of intensive research have finally resulted in label-free technologies in the drug screening marketplace. These technologies provide new ways of interrogating cellular and molecular binding events and enable orthogonal screening approaches to drug targets. The goal of the 4th annual Assay and Screening Technologies Conference is to provide a forum for academics and professionals in the drug discovery industry to stay abreast of exciting new developments in assay technologies while exchanging ideas and developing more efficient approaches to the drug discovery and development process. GTCbio


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009